Vilazodone in patients with generalized anxiety disorder: a double-blind, randomized, placebo-controlled, flexible-dose study

Vilazodone is a selective serotonin reuptake inhibitor and a 5-HT(1A) receptor partial agonist that is approved for treatment of major depressive disorder in adults in the USA and Mexico. The efficacy, safety, and tolerability of vilazodone for generalized anxiety disorder (GAD) were investigated in...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Int Clin Psychopharmacol
Hlavní autoři: Gommoll, Carl, Forero, Giovanna, Mathews, Maju, Nunez, Rene, Tang, Xiongwen, Durgam, Suresh, Sambunaris, Angelo
Médium: Artigo
Jazyk:Inglês
Vydáno: Lippincott Williams And Wilkins 2015
Témata:
Original Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4593467/
https://ncbi.nlm.nih.gov/pubmed/26291335
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/YIC.0000000000000096
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky